Abel, Bastian
Bongartz, Martin
Rapp, Kilian
Roigk, Patrick
Peiter, Janine
Metz, Brigitte
Finger, Benjamin
Büchele, Gisela
Wensing, Michel
Roth, Catharina
Schmidberger, Oliver
König, Hans-Helmut
Gottschalk, Sophie
Dams, Judith
Deuster, Oliver
Immel, Désirée
Micol, William
Bauer, Jürgen M.
Benzinger, Petra
Funding for this research was provided by:
German Innovation Fund (‘New Forms of Care’) coordinated by the Innovation Committee of the Federal Joint Committee, Berlin, Germany (01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017, 01NVF20017)
Universitätsklinikum Heidelberg
Article History
Received: 7 August 2023
Accepted: 22 December 2023
First Online: 17 January 2024
Declarations
:
: The study protocol has been approved by two different ethics committees, as different ethics committees have been responsible for each of the study sites. The Ethics Committee of the Medical Faculty of Heidelberg University approved the study protocol for the consortium-leading study site AGAPLESION BETHANIEN HOSPITAL HEIDELBERG (approval # S-395/2022), whereas the Ethics Committee of the State Medical Association Baden-Württemberg has approved the study protocol for the study sites Robert-Bosch-Hospital Stuttgart and ViDia Christian Clinics Karlsruhe (approval # B-F-2022–057). All procedures in this study involving human participants are in accordance with the recent version of the Declaration of Helsinki. All participants are covered by an insurance while participating in the study. Substantial amendments to the protocol are submitted for approval to the ethical committees and communicated to the trial registry. Written informed consent for study participation is obtained from all of the participants during inpatient rehabilitation prior to study inclusion and baseline assessment.
: Not applicable.
: The authors declare no competing interests.